McDermott Will & Emery advised Berenberg on €250 million Sale of Shares in Dermapharm by Themis Beteiligungs-Aktiengesellschaft
Frankfurt, 16 October 2020 – McDermott Will & Emery advised Joh. Berenberg, Gossler & Co. KG (Berenberg) as sole global coordinator and sole bookrunner on the €250 million sale by the German investor Themis Beteiligungs-Aktiengesellschaft of its shareholdings in Dermapharm Holding SE.
Dermapharm Holding is a leading manufacturer of patent-free branded pharmaceuticals for selected markets in Germany.
The McDermott team led by Simon Weiß and Joseph W. Marx regularly advises Berenberg Bank on capital market transactions, most recently on capital increase of CORESTATE Capital Holding S.A. and the placement of treasury shares of CompuGroup Medical SE & Co. KGaA.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. With more than 20 locations on two continents, our team works seamlessly across practices, industries and geographies to deliver highly effective – and often unexpected – solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.